All News

restless.legs.feet.spasm

Review of Restless Legs Syndrome

Jack Cush, MD

JAMA has published a full read review of RLS - restless leg syndrome - a frequent, but often unrecognized, cause of poor sleep and the resultant hazards of insomnia.

Read Article
2025

The 2025 Rheumatology Year in Review

Jack Cush, MD

The year 2025 presented numerous advances in rheumatology and related inflammatory and autoimmune disorders ranging from several new groundbreaking FDA approvals/indications, drug developments, game-changing guidelines and practices that will impact patient care for rheumatic diseases.

Read Article
PSO.Palmoplantar.jpg

Advanced Practitioner Biologic Prescriptions for Psoriasis

Jack Cush, MD

Advanced practice clinicians (APCs; nurse practitioners and physician assistants) deliver a large share of US dermatologic care, accounting for 37% of clinicians and 27% of dermatology visits by 2020. A current JAMA Dermatology reports APC drug spending trends in dermatology, with a focus on specialty medications (eg, biologics).

Read Article
What Is Restless Legs Syndrome? JAMA Patient Education handout. https://t.co/fCqArVxrSu https://t.co/xjl0PTdgsu

Links:

Dr. John Cush RheumNow ( View Tweet)
Nurse Practitioner Independence A JAMA Viewpoint article reports on a March 2025 Nurse Practitioner (NP) Entrepreneurship Summit in Boston in March 2025 identifying barriers and opportunities to NP-owned medical practices. https://t.co/rkzLwhnNYh https://t.co/bxJWptPQK9

Links:

Dr. John Cush RheumNow ( View Tweet)

2024 Cardiology Income Survey - CV APP salary has incr 15% from 2019 -23, median=$123K - 50% of APP programs lead by an APP >90% work in outpt. clinics - 2/3 of prgs deploy APPs lipid & prevention management - 2 APPs for every 3 cardiologists https://t.co/gtdm5qN1qD https://t.co/cx2JUcw4U3

Links:

Dr. John Cush RheumNow ( View Tweet)
Evaluation of pts w/ muscle weakness and elevated muscle enzymes https://t.co/1Yn3OXXEH6 https://t.co/qsTr4U1xV7

Links:

Dr. John Cush RheumNow ( View Tweet)
Diffuse Alveolar Hemorrhage in Rheumatic Disease A retrospective, cross-sectional, single-center study of adult rheumatic disease patients with diffuse alveolar hemorrhage (DAH), demonstrates a high proportion have coexistent pulmonary infection and significant mortality risk. https://t.co/K1fLo5iHpd
Dr. John Cush RheumNow ( View Tweet)
RheumNow Live is 3 weeks away, and we can't wait to see you there! Why Attend In Person? ✔ Engage directly with faculty during live Q&A ✔ Network with peers who influence and lead in rheumatology ✔ Experience the energy, pace, and collaboration that can’t be replicated https://t.co/Do8srChyXW
Dr. John Cush RheumNow ( View Tweet)
ANAs and Autoantibodies https://t.co/PTdXPMCqjP https://t.co/Pbtgaod3uW

Links:

Dr. John Cush RheumNow ( View Tweet)
FDA & Administration are deregulating artificial intelligence & promote widespread use, includes use of wearables & other AI-enabled devices. Commissioner Marty Makary updated two guidance docs defining use general wellness devices, clinical decision support software https://t.co/KnkYqCiroa
Dr. John Cush RheumNow ( View Tweet)
Spread of Psoriatic Disease from Skin to Joints Approximately 20-30 % of all people who suffer from psoriasis also develop painful inflammation in their joints over time. If left untreated, PsA can lead to permanent damage to bones and joints. Why the disease progresses was https://t.co/UbGHFASKvc
Dr. John Cush RheumNow ( View Tweet)
Metanalysis of 21 clinical trials, 2,100 adults, shows cannabis-based medicines (vs placebo) over 2-26 weeks are not effective in treating chronic neuropathy nerve pain, regardless if given as THC of CBD. https://t.co/ZOJrcMGZkr https://t.co/nqCWoFmaWp

Links:

Dr. John Cush RheumNow ( View Tweet)
"I need the courage to start, the wisdom to say good and the religion to make it a habit" - Ronan Kavanagh of Galway

Dr. John Cush RheumNow ( View Tweet)

2025 Lancet review https://t.co/Qbwup6QxZK of Osteoarthritis did not mention/endorse Rx w/ platelet rich plasma (PRP) prompting several letters of protest. Read the authors response: Despite the popularity of PRP, there are few PBO controlled high quality studies to prove its https://t.co/RCaQVXvvfK

Links:

Dr. John Cush RheumNow ( View Tweet)
New for RheumNow Live 2026! Get more from RheumNow Live 2026—before the meeting begins. Introducing Dr. Mike Putman, Pre-Learn Director, bringing you speaker-selected Pre-Learns and concise video summaries released weekly for registered attendees. 🎥 Watch Now: This week’s PsA https://t.co/vv5XP7EMfu
Dr. John Cush RheumNow ( View Tweet)
Nursing Shortage Could Worsen Due to Limited Student Loans On 11/6, a DOE rule-making committee released a new proposed framework excluding nursing from the so-called "professional degree" category -- a plan which, if finalized, would limit nurses' access to certain student https://t.co/0zpznqgdb7
Dr. John Cush RheumNow ( View Tweet)
Diffuse Alveolar Hemorrhage in Rheumatic Disease A retrospective, cross-sectional, single-center study of adult rheumatic disease patients with diffuse alveolar hemorrhage (DAH), demonstrates a high proportion have coexistent pulmonary infection and significant mortality risk. https://t.co/vpzF8Dnspr
Dr. John Cush RheumNow ( View Tweet)
We're less than 30 days out from RheumNow Live and we want to see you there...in-person! Why Attend In Person? ✔ Engage directly with faculty during live Q&A ✔ Network with peers who influence and lead in rheumatology ✔ Experience the energy, pace, and collaboration that https://t.co/tqSHYAEoOQ
Dr. John Cush RheumNow ( View Tweet)
Join us for STEP Talks at RheumNow Live! Big Ideas. Real Impact. No Filler! https://t.co/vvLKFWatWe Don’t miss these engaging discussions: - Placebos in Rheumatology - Dr. Andreas Kerschbaumer - Disease Modification in Osteoarthritis - Dr. Tuhina Neogi - Helicobacter pylori https://t.co/lQRCLdMSh6

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×